Larger sample-size prospective studies and a unanimous methodology to determine BRCA gene methylation status, as well as a unique laboratory definition of BRCA1 hypermethylated cases, will help in future to draw definitive conclusions about the clinical signature of BRCA1 gene methylated breast cancer in women. This evidence concerns the gene BRCA1 and breast cancer.